New York Medical College Dean Joins the LAM Foundation Scientific Advisory Board
GSBMS Dean will work with the Scientific Advisory Board to advise the LAM Foundation on all scientific matters and formulate the direction of LAM research
Jennifer Riekert, M.B.A.
Vice President of Communications and Strategic Initiatives
New York Medical College
Valhalla, New York – New York Medical College’s (NYMC) Dean of the Graduate School of Basic Medical Sciences, Marina K. Holz, Ph.D., has been named to Scientific Advisory Board of The LAM Foundation. The foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) – a rare lung disease – through advocacy and the funding of promising research.
"LAM is a rare yet devastating disease that primarily affects women,” said Dr. Holz. “I have been working with The LAM Foundation for years. The organization has awarded grants to support my research and I know first-hand how important the foundation is to finding a cure and to helping patients living with this disease. I am thrilled to have been selected to serve as a member of The LAM Foundation Scientific Advisory Board so I can continue to support their vital work.”
As a member of the board, Dr. Holz will serve the organization in various ways, including: serving as a reviewer for the LAM Scientific Research program; providing clinical and/or scientific expertise; preparing articles for LAM Foundation publications; contributing information on new clinical information, publications, and conferences; giving presentations on specific issues in LAM; and serving as a resource to LAM patients.
Contributing her extensive expertise to the foundation, Dr. Holz leads an NIH-funded laboratory studying the mechanisms of signaling by hormones and growth factors in breast cancer and LAM. Her work spans basic science and clinical applications and has been published in leading journals. In addition to The LAM Foundation, the Holz lab has been previously funded by grants from the American Cancer Society, Wendy Will Case Cancer Fund, American Association for Cancer Research, Mindlin Foundation, National Cancer Center and Atol Foundation.
Dr. Holz also serves as a peer reviewer for multiple journals and participates in grant review study sections for the NIH, Department of Defense, ACS, and many international funding agencies.
Dr. Holz is a member of the Albert Einstein Cancer Center of the Albert Einstein College of Medicine. She received her B.Sc. in microbiology and immunology with Great Distinction from McGill University and completed her Ph.D. in cell and developmental biology at Harvard Medical School.
The members of the Scientific Advisory Board serve a renewable three-year term.
About New York Medical College
Founded in 1860, New York Medical College is one of the oldest and largest health sciences colleges in the country with nearly 1,500 students and 330 residents and clinical fellows, more than 2,600 faculty members and 23,200 living alumni. The College, which joined the Touro College and University System in 2011, is located in Westchester County, New York, and offers degrees from the School of Medicine, the Graduate School of Basic Medical Sciences, the School of Health Sciences and Practice, a School of Dental Medicine and a School of Nursing. NYMC provides a wide variety of clinical training opportunities for students, residents, and practitioners.